<DOC>
	<DOCNO>NCT02127294</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety transcatheter patent foramen ovale closure migraine .</brief_summary>
	<brief_title>Effectiveness Safety Transcatheter Patent Foramen Ovale Closure Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Foramen Ovale , Patent</mesh_term>
	<criteria>Clinical history migraine diagnose neurologist accord International Classification Headache Disorders Transcranial Doppler evidence righttoleft shunt ( RLS ) echocardiographic evidence PFOï¼Œof degree moderate large RLS Subjects respond take common migraine preventive medication Willing participate followup visit Additional Transcatheter closure group : Closure PFO perform Contrast group : Subjects meet Inclusion Criteria , refuse undergo closure procedure Seizure disorder Other organic central nervous system disease Subjects whose headache migraine , result traumatic head neck injury Evidence alcohol , drug substance abuse within previous year Additional Exclusion Criteria Transcatheter closure group : Subjects intracardiac thrombus tumor Subjects acute recent ( within 6 month ) myocardial infarction unstable angina Subjects leave ventricular aneurysm akinesis Subjects atrial fibrillation/atrial flutter ( chronic intermittent ) Subjects another source right leave shunt identify baseline , include atrial septal defect and/or fenestrated septum Subjects contraindication aspirin Clopidogrel therapy Pregnant desire become pregnant within next year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Foramen Ovale , Patent</keyword>
	<keyword>migraine</keyword>
	<keyword>transcatheter patent foramen ovale closure</keyword>
	<keyword>contrast-enhanced transcranial Doppler</keyword>
	<keyword>Transthoracic Echocardiography</keyword>
</DOC>